These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 7195898

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tetrahydropyranyl derivatives of daunomycin and adriamycin.
    Umezawa H, Takahashi Y, Kinoshita M, Naganawa H, Masuda T, Ishizuka M, Tatsuta K, Takeuchi T.
    J Antibiot (Tokyo); 1979 Oct; 32(10):1082-4. PubMed ID: 528373
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Syntheses and antitumor activities of 7-O-(3-amino-2,3,6-trideoxy-2-fluoro-alpha-L-talopyranosyl)daunomvcinone and -adriamycinone.
    Takagi Y, Park H, Tsuchiya T, Umezawa S, Takeuchi T, Komuro K, Nosaka C.
    J Antibiot (Tokyo); 1989 Aug; 42(8):1315-7. PubMed ID: 2759914
    [No Abstract] [Full Text] [Related]

  • 7. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
    DuVernay VH, Pachter JA, Crooke ST.
    Cancer Res; 1980 Feb; 40(2):387-94. PubMed ID: 7356521
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Syntheses and antitumor activities of 7-O-(6-deoxy-2-O-methyl-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Takagi Y, Kobayashi N, Tsuchiya T, Umezawa S, Takeuchi T, Komuro K, Nosaka C.
    J Antibiot (Tokyo); 1989 Aug; 42(8):1318-20. PubMed ID: 2759915
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
    Takagi Y, Kobayashi N, Chang MS, Lim GJ, Tsuchiya T.
    Carbohydr Res; 1998 Feb; 307(3-4):217-32. PubMed ID: 9675364
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis of daunorubicin analogues with novel 9-acyl substituents.
    Smith TH, Fujiwara AN, Henry DW.
    J Med Chem; 1979 Jan; 22(1):40-4. PubMed ID: 423182
    [Abstract] [Full Text] [Related]

  • 15. 3'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity.
    Horton D, Priebe W, Varela O.
    J Antibiot (Tokyo); 1984 Dec; 37(12):1635-41. PubMed ID: 6549317
    [Abstract] [Full Text] [Related]

  • 16. Total synthesis of the antitumor antibiotic danuorubicin. Coupling of the sugar and aglycone.
    Acton EM, Fujiwara AN, Henry DW.
    J Med Chem; 1974 Jun; 17(6):659-60. PubMed ID: 4829947
    [No Abstract] [Full Text] [Related]

  • 17. Adriamycin (NSC-123127) and its analogs.
    Henry DW.
    Cancer Chemother Rep 2; 1974 Dec; 4(4):5-9. PubMed ID: 4451911
    [No Abstract] [Full Text] [Related]

  • 18. Adriamycin analogs hydroxylated at c-3': synthesis and antitumor activity.
    Horton D, Turner WR.
    Carbohydr Res; 1979 Dec; 77():C8-C11. PubMed ID: 519652
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    Stefańska B, Dzieduszycka M, Bontemps-Gracz M, Borowski E, Martelli S.
    J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
    [Abstract] [Full Text] [Related]

  • 20. Adriamycin analogues. Preparation and biological evaluation of some N-perfluoroacyl analogues of daunorubicin, adriamycin, and N-(trifluoroacetyl)adriamycin 14-valerate and their 9,10-anhydro derivatives.
    Israel M, Potti G.
    J Med Chem; 1982 Feb; 25(2):187-91. PubMed ID: 7057426
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.